SUBSTITUTED N,2-DIARYLQUINOLINE-4-CARBOXAMIDES AND THE USE THEREOF AS ANTI-INFLAMMATORY AGENTS
申请人:BAYER PHARMA AKTIENGESELLSCHAFT
公开号:US20170260140A1
公开(公告)日:2017-09-14
The present application relates to novel substituted N,2-diarylquinoline-4-carboxamide derivatives, to processes for preparation thereof, to the use thereof alone or in combinations for treatment and/or prevention of diseases, and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially for treatment and/or prevention of fibrotic and/or inflammatory disorders.
本申请涉及新颖的取代N,2-二芳基喹啉-4-甲酰胺衍生物,其制备方法,单独或组合使用以治疗和/或预防疾病,以及用于生产治疗和/或预防疾病的药物,特别是用于治疗和/或预防纤维化和/或炎症性疾病。